Cargando…
Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group
Hypertension (HTN) is frequently associated with the use of angiogenesis inhibitors targeting the vascular endothelial growth factor pathway and appears to be a generalized effect of this class of agent. We investigated the phenomenon in 61 patients with advanced hepatocellular carcinoma (HCC) recei...
Autores principales: | Gardini, Andrea Casadei, Scarpi, Emanuela, Marisi, Giorgia, Foschi, Francesco Giuseppe, Donati, Gabriele, Giampalma, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Bisulli, Marcello, Corbelli, Jody, Gardini, Andrea, Barba, Giuliano La, Veneroni, Luigi, Tamberi, Stefano, Cascinu, Stefano, Frassineti, Giovanni Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924783/ https://www.ncbi.nlm.nih.gov/pubmed/26893366 http://dx.doi.org/10.18632/oncotarget.7444 |
Ejemplares similares
-
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study
por: Gardini, Andrea Casadei, et al.
Publicado: (2016) -
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib
por: Gardini, Andrea Casadei, et al.
Publicado: (2016) -
Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV
por: De Matteis, Serena, et al.
Publicado: (2021) -
No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC)
por: Capelli, Laura, et al.
Publicado: (2016) -
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin
por: De Matteis, Serena, et al.
Publicado: (2019)